Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Taoyuan District listing was replaced with Taoyuan, reflecting a city-level designation with the same postal code 33305. This aligns the location with the actual site and improves accuracy for recruitment and contact information.
    Difference
    0.0%
    Check dated 2026-05-04T01:32:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s displayed software/site revision indicator has been updated from v3.5.0 to v3.5.3. This represents a maintenance/frontend version change rather than an update to the clinical trial information presented.
    Difference
    0.0%
    Check dated 2026-04-26T15:20:58.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    49 days ago
    Change Detected
    Summary
    Site listing updated from Napoli, Italy, 80131 to Naples, Italy, 80131. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T16:32:52.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:40:12.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; this is a minor maintenance update with no visible changes to study data or navigation, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:01.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:28:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.